Rivabazumab

• Description:

  Rivabazumab is a recombinant antibody against Pseudomonas aeruginosa pcrV[1].

• Product Name Alternative:

  KB001

• UNSPSC:

  12352203

• Target:

  Bacterial

• Type:

  Inhibitory Antibodies

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/rivabazumab.html

• Purity:

  99

• Solubility:

  10 mM in DMSO

• Smiles:

  [Rivabazumab]

• References & Citations:

  [1]Wenshe Ray LIU, et al. Protease switch for dual targets chimeric antigen receptor t cell therapy. WO2021087245.

• Shipping Conditions:

  Dry Ice

• Storage Conditions:

  Store at -80°C for 2 years

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported

• CAS Number:

  [1627519-84-9]